Ruquan Han
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ruquan Han has a total of 289 co-authors. Here are the top co-authors by number of shared publications:
Minyu Jian
Department of Anesthesiology Beijing TianTan Hospital, Capital Medical University Beijing China
22 shared publicationsFa Liang
Department of Anesthesiology, Beijing Tiantan Hospital, Capital Medical University
21 shared publicationsHaiyang Liu
Departments of Anesthesiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
20 shared publicationsYouxuan Wu
Department of Anesthesiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic of China
20 shared publicationsXinyan Wang
Department of Anesthesiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic of China
19 shared publicationsAnxin Wang
Department of Statistics, China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
13 shared publications
Latest Publications
- Open Access
- 1 November 2026
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 20, 1-12
Effect of Two Desflurane Concentration-Based Anesthetic Strategies on Flash Visual Evoked Potential Monitoring During Spine Surgery: A Randomized Superiority Trial
Purpose: Intraoperative flash visual-evoked potential (FVEP) monitoring is valuable for assessing visual function. However, it can be influenced by inhaled anesthetics. This trial aimed to compare two desflurane concentration-based anesthetic strategies for FVEP monitoring. Patients and Methods: Seventy patients undergoing elective spinal surgery were enrolled in this prospective, randomized controlled, superiority trial and randomized 1:1 to either the desflurane-based balanced anesthesia group (BA group), receiving 0.5 MAC desflurane with propofol and remifentanil, or the desflurane-dominant inhalational anesthesia group (IA group), receiving 0.7– 1.0 MAC desflurane with remifentanil. Baseline measurement in both groups was obtained 30 min after induction (T1) under total intravenous anesthesia (TIVA). The primary outcome was N75-P100 amplitude measured 60 min after induction (T2). Secondary outcomes included decline rates of N75-P100 and P100-N145 amplitudes from T1 to T2. Results: Among 69 analyzed patients (35 in the BA group and 34 in the IA group), the N75-P100 amplitude of BA group was significantly superior (10.1 [5.2] μV vs 6.3 [2.7] μV; δ = 0.47 μV; mean difference = 3.81 μV, 95% CI: 1.81 to 5.80 (μV); P for superiority < 0.001). The median [IQR] decline rates of the N75-P100 amplitude (0.16 [− 0.04 to 0.25] vs 0.49 [0.40 to 0.57], P < 0.001) and the P100-N145 amplitude (0.08 [− 0.11 to 0.20] vs 0.44 [0.36 to 0.56], P < 0.001) from T1 to T2 were significantly higher in the IA group than in the BA group. Conclusion: Desflurane-based balanced anesthesia is superior to desflurane-dominant inhalational anesthesia for preserving FVEP waveforms. When volatile anesthesia is required, the 0.5 MAC desflurane-based balanced regimen may serve as a viable alternative option for intraoperative FVEP monitoring. A) Infographic step 1: 69 patients, with an icon of three people and a spine illustration. B) Infographic step 2: BA versus IA. BA: 0.5 MAC desflurane plus propofol plus remifentanil. IA: 0.7 to 1.0 MAC desflurane plus remifentanil. Syringe and vial icons appear next to each group. C) Infographic step 3: Better preservation of FVEP amplitude at T2, with a brain illustration. A bar chart shows y axis label, FVEP amplitude, unit not shown and x axis labels, BA and IA, unit not shown; the BA bar is taller than the IA bar. A curved arrow points upward from the bars toward the brain illustration. Bottom text: 0.5 MAC desflurane based balanced anesthesia is a feasible option during intraoperative FVEP monitoring.An infographic of 69 patients comparing BA versus IA anesthesia and FVEP amplitude at T2. Plain Language Summary: Question: Flash visual evoked potential (FVEP) monitoring during spine surgery to help preserve patients’ visual function. Total intravenous anesthesia is widely considered the best anesthesia choice for this monitoring. However, it remains unclear how different concentrations of inhaled anesthetic gas affect FVEP signals. We aimed to find out whether higher or lower levels of desflurane change these FVEP waveforms during spine surgery. Findings: We found 0.5MAC desflurane worked better for preserving FVEP signals than 0.7-1.0 MAC desflurane. Meaning: These findings suggest that 0.5 MAC desflurane combined with a propofol-remifentanil regimen is a feasible anesthetic protocol for intraoperative FVEP monitoring when volatile anesthesia is required.
- 1 November 2026
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 20, 1-12
Open AccessEffect of Two Desflurane Concentration-Based Anesthetic Strategies on Flash Visual Evoked Potential Monitoring During Spine Surgery: A Randomized Superiority Trial
Purpose: Intraoperative flash visual-evoked potential (FVEP) monitoring is valuable for assessing visual function. However, it can be influenced by inhaled anesthetics. This trial aimed to compare two desflurane concentration-based anesthetic strategies for FVEP monitoring. Patients and Methods: Seventy patients undergoing elective spinal surgery were enrolled in this prospective, randomized controlled, superiority trial and randomized 1:1 to either the desflurane-based balanced anesthesia group (BA group), receiving 0.5 MAC desflurane with propofol and remifentanil, or the desflurane-dominant inhalational anesthesia group (IA group), receiving 0.7– 1.0 MAC desflurane with remifentanil. Baseline measurement in both groups was obtained 30 min after induction (T1) under total intravenous anesthesia (TIVA). The primary outcome was N75-P100 amplitude measured 60 min after induction (T2). Secondary outcomes included decline rates of N75-P100 and P100-N145 amplitudes from T1 to T2. Results: Among 69 analyzed patients (35 in the BA group and 34 in the IA group), the N75-P100 amplitude of BA group was significantly superior (10.1 [5.2] μV vs 6.3 [2.7] μV; δ = 0.47 μV; mean difference = 3.81 μV, 95% CI: 1.81 to 5.80 (μV); P for superiority < 0.001). The median [IQR] decline rates of the N75-P100 amplitude (0.16 [− 0.04 to 0.25] vs 0.49 [0.40 to 0.57], P < 0.001) and the P100-N145 amplitude (0.08 [− 0.11 to 0.20] vs 0.44 [0.36 to 0.56], P < 0.001) from T1 to T2 were significantly higher in the IA group than in the BA group. Conclusion: Desflurane-based balanced anesthesia is superior to desflurane-dominant inhalational anesthesia for preserving FVEP waveforms. When volatile anesthesia is required, the 0.5 MAC desflurane-based balanced regimen may serve as a viable alternative option for intraoperative FVEP monitoring. A) Infographic step 1: 69 patients, with an icon of three people and a spine illustration. B) Infographic step 2: BA versus IA. BA: 0.5 MAC desflurane plus propofol plus remifentanil. IA: 0.7 to 1.0 MAC desflurane plus remifentanil. Syringe and vial icons appear next to each group. C) Infographic step 3: Better preservation of FVEP amplitude at T2, with a brain illustration. A bar chart shows y axis label, FVEP amplitude, unit not shown and x axis labels, BA and IA, unit not shown; the BA bar is taller than the IA bar. A curved arrow points upward from the bars toward the brain illustration. Bottom text: 0.5 MAC desflurane based balanced anesthesia is a feasible option during intraoperative FVEP monitoring.An infographic of 69 patients comparing BA versus IA anesthesia and FVEP amplitude at T2. Plain Language Summary: Question: Flash visual evoked potential (FVEP) monitoring during spine surgery to help preserve patients’ visual function. Total intravenous anesthesia is widely considered the best anesthesia choice for this monitoring. However, it remains unclear how different concentrations of inhaled anesthetic gas affect FVEP signals. We aimed to find out whether higher or lower levels of desflurane change these FVEP waveforms during spine surgery. Findings: We found 0.5MAC desflurane worked better for preserving FVEP signals than 0.7-1.0 MAC desflurane. Meaning: These findings suggest that 0.5 MAC desflurane combined with a propofol-remifentanil regimen is a feasible anesthetic protocol for intraoperative FVEP monitoring when volatile anesthesia is required.
- 13 October 2026
- Published by Wiley in Journal of Sleep Research
Effects of General Anaesthesia on the Sleep Structure of Patients With Prolonged Disorders of Consciousness
Sleep disturbances are common in patients with prolonged disorders of consciousness (pDoC) and are closely correlated with clinical outcomes. With an increasing number of pDoC patients undergoing surgery under general anaesthesia (GA), this study characterized sleep patterns in pDoC patients and evaluated the effects of GA on consciousness and nocturnal sleep. We prospectively enrolled 30 pDoC patients (14 in vegetative state [VS] and 16 in minimally conscious state [MCS]) undergoing spinal cord stimulation and 12 healthy controls. Among pDoC patients, 19 (10 VS, 9 MCS) with complete pre‐ and postoperative PSG data were analysed for GA effects. Controls underwent one overnight polysomnography (PSG); pDoC patients underwent pre‐ and postoperative PSG. Consciousness was assessed with Coma Recovery Scale‐Revised (CRS‐R) before and after surgery. Compared with controls, pDoC patients presented significantly impaired sleep structure, including reduced total sleep time (TST), decreased NREM Stage 2 sleep, diminished slow‐wave sleep (SWS), reduced rapid eye movement (REM) sleep duration and percentage relative to TST (all p < 0.05). No significant short‐term changes in CRS‐R scores were observed following GA. Although GA significantly prolonged TST ( p = 0.039), with numerical increases in absolute NREM and SWS durations, no statistically significant changes were observed in sleep stage percentages relative to TST (all p > 0.05). Subgroup analysis showed no significant within‐group changes in sleep stage percentages in either the VS or MCS group. These findings suggest that GA increases TST without statistically significant changes in sleep structure in pDoC patients.
- 13 October 2026
- Published by Wiley in Journal of Sleep Research
Effects of General Anaesthesia on the Sleep Structure of Patients With Prolonged Disorders of Consciousness
Sleep disturbances are common in patients with prolonged disorders of consciousness (pDoC) and are closely correlated with clinical outcomes. With an increasing number of pDoC patients undergoing surgery under general anaesthesia (GA), this study characterized sleep patterns in pDoC patients and evaluated the effects of GA on consciousness and nocturnal sleep. We prospectively enrolled 30 pDoC patients (14 in vegetative state [VS] and 16 in minimally conscious state [MCS]) undergoing spinal cord stimulation and 12 healthy controls. Among pDoC patients, 19 (10 VS, 9 MCS) with complete pre‐ and postoperative PSG data were analysed for GA effects. Controls underwent one overnight polysomnography (PSG); pDoC patients underwent pre‐ and postoperative PSG. Consciousness was assessed with Coma Recovery Scale‐Revised (CRS‐R) before and after surgery. Compared with controls, pDoC patients presented significantly impaired sleep structure, including reduced total sleep time (TST), decreased NREM Stage 2 sleep, diminished slow‐wave sleep (SWS), reduced rapid eye movement (REM) sleep duration and percentage relative to TST (all p < 0.05). No significant short‐term changes in CRS‐R scores were observed following GA. Although GA significantly prolonged TST ( p = 0.039), with numerical increases in absolute NREM and SWS durations, no statistically significant changes were observed in sleep stage percentages relative to TST (all p > 0.05). Subgroup analysis showed no significant within‐group changes in sleep stage percentages in either the VS or MCS group. These findings suggest that GA increases TST without statistically significant changes in sleep structure in pDoC patients.
- 2 September 2026
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
Disruption of Sensorimotor Network Connectivity in Patients With Supratentorial Gliomas During Mild Sedation With Midazolam: An Exploratory Interventional Study
Introduction: Midazolam has been shown to induce transient motor deficits in patients with supratentorial gliomas. However, its effects on brain networks remain unclear, given the compensatory network reorganization in response to tumor-induced damage. This study examined sensorimotor network (SMN) intra- and internetwork functional connectivity before and after midazolam mild sedation in patients with motor cortex gliomas, compared with healthy controls. Methods: Glioma patients and healthy volunteers underwent resting-state functional MRI in the awake state and mild midazolam sedation. Regions of interest were defined in the primary motor cortex (M1) using a 6 mm radius. Statistical significance was set at an uncorrected voxel-wise threshold of P P P P P =0.01), and between M1 and the occipital fusiform gyrus/inferior lateral occipital cortex (T=5.88 and P =0.002). Conclusion: Midazolam mild sedation alters SMN connectivity in glioma patients, characterized by enhanced intranetwork compensation and impaired cross-network integration. These findings suggest potential vulnerabilities of functional brain networks during the perioperative period.
- 2 September 2026
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
Disruption of Sensorimotor Network Connectivity in Patients With Supratentorial Gliomas During Mild Sedation With Midazolam: An Exploratory Interventional Study
Introduction: Midazolam has been shown to induce transient motor deficits in patients with supratentorial gliomas. However, its effects on brain networks remain unclear, given the compensatory network reorganization in response to tumor-induced damage. This study examined sensorimotor network (SMN) intra- and internetwork functional connectivity before and after midazolam mild sedation in patients with motor cortex gliomas, compared with healthy controls. Methods: Glioma patients and healthy volunteers underwent resting-state functional MRI in the awake state and mild midazolam sedation. Regions of interest were defined in the primary motor cortex (M1) using a 6 mm radius. Statistical significance was set at an uncorrected voxel-wise threshold of P P P P P =0.01), and between M1 and the occipital fusiform gyrus/inferior lateral occipital cortex (T=5.88 and P =0.002). Conclusion: Midazolam mild sedation alters SMN connectivity in glioma patients, characterized by enhanced intranetwork compensation and impaired cross-network integration. These findings suggest potential vulnerabilities of functional brain networks during the perioperative period.
- 30 July 2026
- Published by Wolters Kluwer Health in Anesthesiology
Choice of Anesthesia in Microelectrode Recording–guided Deep Brain Stimulation Surgery for Parkinson’s Disease (CHAMPION): A Noninferiority Randomized Controlled Trial
Background: Deep brain stimulation for Parkinson’s disease is often performed under conscious sedation or general anesthesia. However, anesthetic agents may influence intraoperative microelectrode recording, and the optimal anesthesia method for microelectrode recording remains unclear. This study compared general anesthesia and conscious sedation in preserving microelectrode recording signal intensity during deep brain stimulation. Methods: In this prospective, noninferiority randomized controlled trial, patients with Parkinson’s disease (United Kingdom Brain Bank criteria) undergoing elective bilateral surgery were randomized 1:1 to the conscious sedation or the general anesthesia group. During surgery, a desflurane anesthetic titrated against the quality of the electrophysiologic signal was applied in the general anesthesia group, whereas patients in the conscious sedation group received dexmedetomidine anesthesia. The primary outcome was the proportion of patients with high-quality microelectrode recording (normalized root mean square greater than 2.0), assessed postoperatively off-line. Secondary outcomes included operation and recording duration, 6-month clinical efficacy, and complication rates. Results: Of 188 randomized patients (94 general anesthesia, 93 conscious sedation), desflurane anesthesia was noninferior for high normalized root mean square proportion (89.4% vs . 90.3%; difference, –0.96%; 95% CI, –9.62 to 7.70). The general anesthesia group had shorter operative time (difference, –9.07 min; 95% CI, –13.99 to –4.14; P < 0.001). At 6 months, changes in Unified Parkinson’s Disease Rating Scale score (difference, –2.50; 95% CI, –7.20 to 2.20; P = 0.297), levodopa equivalent daily dose (difference, –58.4 mg; 95% CI, –133.56 to 16.75; P = 0.128), and complication rates (general anesthesia: 10.9% vs . conscious sedation: 8.9%; P = 0.655) were comparable between the groups. Conclusions: General anesthesia is noninferior to conscious sedation for microelectrode-guided subthalamic nucleus deep brain stimulation, providing equivalent signal intensity and clinical outcomes while improving procedural efficiency, supporting its use as a valid clinical option.
- 30 July 2026
- Published by Wolters Kluwer Health in Anesthesiology
Choice of Anesthesia in Microelectrode Recording–guided Deep Brain Stimulation Surgery for Parkinson’s Disease (CHAMPION): A Noninferiority Randomized Controlled Trial
Background: Deep brain stimulation for Parkinson’s disease is often performed under conscious sedation or general anesthesia. However, anesthetic agents may influence intraoperative microelectrode recording, and the optimal anesthesia method for microelectrode recording remains unclear. This study compared general anesthesia and conscious sedation in preserving microelectrode recording signal intensity during deep brain stimulation. Methods: In this prospective, noninferiority randomized controlled trial, patients with Parkinson’s disease (United Kingdom Brain Bank criteria) undergoing elective bilateral surgery were randomized 1:1 to the conscious sedation or the general anesthesia group. During surgery, a desflurane anesthetic titrated against the quality of the electrophysiologic signal was applied in the general anesthesia group, whereas patients in the conscious sedation group received dexmedetomidine anesthesia. The primary outcome was the proportion of patients with high-quality microelectrode recording (normalized root mean square greater than 2.0), assessed postoperatively off-line. Secondary outcomes included operation and recording duration, 6-month clinical efficacy, and complication rates. Results: Of 188 randomized patients (94 general anesthesia, 93 conscious sedation), desflurane anesthesia was noninferior for high normalized root mean square proportion (89.4% vs . 90.3%; difference, –0.96%; 95% CI, –9.62 to 7.70). The general anesthesia group had shorter operative time (difference, –9.07 min; 95% CI, –13.99 to –4.14; P < 0.001). At 6 months, changes in Unified Parkinson’s Disease Rating Scale score (difference, –2.50; 95% CI, –7.20 to 2.20; P = 0.297), levodopa equivalent daily dose (difference, –58.4 mg; 95% CI, –133.56 to 16.75; P = 0.128), and complication rates (general anesthesia: 10.9% vs . conscious sedation: 8.9%; P = 0.655) were comparable between the groups. Conclusions: General anesthesia is noninferior to conscious sedation for microelectrode-guided subthalamic nucleus deep brain stimulation, providing equivalent signal intensity and clinical outcomes while improving procedural efficiency, supporting its use as a valid clinical option.
- 15 June 2026
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
Acute Effects of Esketamine on the EEG Power Spectrum and Signal Complexity in Prolonged Disorders of Consciousness: A Prospective Exploratory Cohort Study
Background: Effective treatments for prolonged disorders of consciousness (pDoC) remain limited. Grounded in the entropic brain hypothesis—that psychedelic agents facilitate consciousness recovery by increasing brain complexity—this study investigated esketamine, a nonclassical psychedelic drug, and its effects on electroencephalographic (EEG) neurophysiological metrics in pDoC patients. Methods: In this prospective exploratory cohort study, 27 patients with pDoC were enrolled, and 22 with sufficient EEG signal quality were included in the final analysis. Patients were diagnosed with vegetative state/unresponsive wakefulness syndrome (VS/UWS) or a minimally conscious state (MCS). Patients received a 1-hour intravenous infusion of esketamine (0.3 mg/kg/h). EEG data were collected at baseline, 1 hour after infusion, and 30 minutes post-discontinuation. The power spectral density and Lempel-Ziv complexity (LZC) were analyzed. The study was registered at ClinicalTrials.gov (NCT06473285) on June 23, 2024. Results: Esketamine reshaped the EEG power spectrum, suppressing global delta relative power ( p_FDR =0.040) while increasing beta ( p_FDR =0.040) and gamma ( p_FDR =0.009) relative power. The alpha relative power increased selectively in the VS/UWS ( p_FDR =0.012). The LZC increased in the parietal ( P =0.030) and occipital ( P =0.007) regions. In MCS patients, the increase in LZC persisted for 30 minutes post-discontinuation, most prominently in the occipital region, whereas changes in VS/UWS were transient. No behavioral improvements were observed on the Coma Recovery Scale-Revised assessments. Conclusions: Esketamine-induced neurophysiological alterations in patients with pDoC are characterized by reorganization of the EEG power spectral density and region-specific increases in signal complexity. However, these changes were not accompanied by improvements in behavioral responsiveness.
- 15 June 2026
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
Acute Effects of Esketamine on the EEG Power Spectrum and Signal Complexity in Prolonged Disorders of Consciousness: A Prospective Exploratory Cohort Study
Background: Effective treatments for prolonged disorders of consciousness (pDoC) remain limited. Grounded in the entropic brain hypothesis—that psychedelic agents facilitate consciousness recovery by increasing brain complexity—this study investigated esketamine, a nonclassical psychedelic drug, and its effects on electroencephalographic (EEG) neurophysiological metrics in pDoC patients. Methods: In this prospective exploratory cohort study, 27 patients with pDoC were enrolled, and 22 with sufficient EEG signal quality were included in the final analysis. Patients were diagnosed with vegetative state/unresponsive wakefulness syndrome (VS/UWS) or a minimally conscious state (MCS). Patients received a 1-hour intravenous infusion of esketamine (0.3 mg/kg/h). EEG data were collected at baseline, 1 hour after infusion, and 30 minutes post-discontinuation. The power spectral density and Lempel-Ziv complexity (LZC) were analyzed. The study was registered at ClinicalTrials.gov (NCT06473285) on June 23, 2024. Results: Esketamine reshaped the EEG power spectrum, suppressing global delta relative power ( p_FDR =0.040) while increasing beta ( p_FDR =0.040) and gamma ( p_FDR =0.009) relative power. The alpha relative power increased selectively in the VS/UWS ( p_FDR =0.012). The LZC increased in the parietal ( P =0.030) and occipital ( P =0.007) regions. In MCS patients, the increase in LZC persisted for 30 minutes post-discontinuation, most prominently in the occipital region, whereas changes in VS/UWS were transient. No behavioral improvements were observed on the Coma Recovery Scale-Revised assessments. Conclusions: Esketamine-induced neurophysiological alterations in patients with pDoC are characterized by reorganization of the EEG power spectral density and region-specific increases in signal complexity. However, these changes were not accompanied by improvements in behavioral responsiveness.
- 15 June 2026
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
- Vol. 38 (4) , 372-373
Response to correspondence “Outcome Hierarchy Matters When Interpreting Emergency Conversion to General Anesthesia During EVT”
- 15 June 2026
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
- Vol. 38 (4) , 372-373
Response to correspondence “Outcome Hierarchy Matters When Interpreting Emergency Conversion to General Anesthesia During EVT”
- Open Access
- 12 May 2026
- Published by Elsevier in Pharmacological Research
- Vol. 229, 108238
Effect of intraoperative esketamine on moderate-to-severe depressive symptoms in major surgery patients: A randomized clinical trial
- 12 May 2026
- Published by Elsevier in Pharmacological Research
- Vol. 229, 108238
Open AccessEffect of intraoperative esketamine on moderate-to-severe depressive symptoms in major surgery patients: A randomized clinical trial
- Open Access
- 11 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Target trial emulation of early acetaminophen use and mortality in critically ill stroke patients
The role of acetaminophen in managing critically ill patients with acute ischemic stroke (AIS) is debated. While it is commonly used for fever and pain, its direct impact on mortality in the intensive care unit (ICU) setting is unclear. This study aims to estimate the causal effect of early acetaminophen administration on mortality in critically ill adults with AIS. This study employed a target trial using retrospective data from the MIMIC-IV database (2008–2019, 1779 patients) and an external validation cohort in the eICU database (1182 patients). We compared acetaminophen (ACE) use within 48 h of ICU admission with non-ACE use within 48 h and used clone-censor-weight methods for the main analysis. The primary outcomes were 30-day and 90-day all-cause mortality. Furthermore, the findings were substantiated by sensitivity analyses, competing risk models, and subgroup analyses. In the primary CCW-weighted analysis, early acetaminophen administration was associated with a statistically significant reduction in 90-day all-cause mortality (HR, 0.70; 95% CI 0.58–0.84; P < 0.001). Similarly, the 30-day mortality risk was significantly lower in the ACE group (HR, 0.66; 95% CI 0.54–0.81). Early acetaminophen administration was associated with reduced mortality in critically ill AIS patients, particularly those without diabetes. Despite the variability in external validation, these findings suggest a phenotype-specific survival benefit warranting confirmation in precision-based randomized trials.
- 11 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessTarget trial emulation of early acetaminophen use and mortality in critically ill stroke patients
The role of acetaminophen in managing critically ill patients with acute ischemic stroke (AIS) is debated. While it is commonly used for fever and pain, its direct impact on mortality in the intensive care unit (ICU) setting is unclear. This study aims to estimate the causal effect of early acetaminophen administration on mortality in critically ill adults with AIS. This study employed a target trial using retrospective data from the MIMIC-IV database (2008–2019, 1779 patients) and an external validation cohort in the eICU database (1182 patients). We compared acetaminophen (ACE) use within 48 h of ICU admission with non-ACE use within 48 h and used clone-censor-weight methods for the main analysis. The primary outcomes were 30-day and 90-day all-cause mortality. Furthermore, the findings were substantiated by sensitivity analyses, competing risk models, and subgroup analyses. In the primary CCW-weighted analysis, early acetaminophen administration was associated with a statistically significant reduction in 90-day all-cause mortality (HR, 0.70; 95% CI 0.58–0.84; P < 0.001). Similarly, the 30-day mortality risk was significantly lower in the ACE group (HR, 0.66; 95% CI 0.54–0.81). Early acetaminophen administration was associated with reduced mortality in critically ill AIS patients, particularly those without diabetes. Despite the variability in external validation, these findings suggest a phenotype-specific survival benefit warranting confirmation in precision-based randomized trials.
- Open Access
- 31 March 2026
- Published by Springer Nature in BMC Anesthesiology
- Vol. 26 (1)
Red blood cell transfusion in neurocritical patients: an updated systematic review and meta-analysis
Anemia is a prevalent complication in neurocritical patients and contributes to secondary brain damage by diminishing the oxygen supply to the brain. Altho
- 31 March 2026
- Published by Springer Nature in BMC Anesthesiology
- Vol. 26 (1)
Open AccessRed blood cell transfusion in neurocritical patients: an updated systematic review and meta-analysis
Anemia is a prevalent complication in neurocritical patients and contributes to secondary brain damage by diminishing the oxygen supply to the brain. Altho
- 23 February 2026
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
- Vol. 38 (4) , 358-364
Early Oxygenation Levels and Clinical Outcomes in Postendovascular Therapy Ischemic Stroke: An Exploratory Analysis of the RESCUE-RE Registry
Background: Studies on oxygenation in acute ischemic stroke (AIS) mainly focus on the prehospital care and during endovascular therapy (EVT). This study aimed to explore the association between arterial oxygenation levels within the first 24 hours of intensive care unit (ICU) admission and neurological recovery, as well as pulmonary complications in AIS patients after EVT. Methods: We conducted an exploratory analysis of the multicenter RESCUE-RE registry, including 532 AIS patients who underwent EVT at 18 comprehensive stroke centers in China from January 2019 to June 2024. Patients were categorized by arterial blood gas measurements within 24 hours post-ICU admission into hypoxemia (PaO 2 120 mm Hg) groups. The primary outcome was functional independence (modified Rankin Scale [mRS] score 0 to 2) at 90 days. Secondary outcomes included other mRS thresholds, 90-day all-cause mortality, neurological improvement/deterioration, and pulmonary infection incidence. Multivariable regression adjusted for confounders assessed associations between PaO 2 levels and outcomes. Results: Functional independence rates at 90 days did not differ significantly among hypoxemia (26.8%), normoxemia (27.2%), and hyperoxemia (24.5%) groups ( P =0.788). Adjusted analyses showed no significant association between PaO 2 levels and neurological outcomes or mortality. Secondary outcomes, including neurological changes, were also comparable across groups. Notably, normoxemia and hyperoxemia were associated with significantly lower pulmonary infection risk compared with hypoxemia (adjusted ORs: 0.48 to 0.63). Conclusions: In AIS patients undergoing EVT, early postoperative arterial oxygenation was not associated with 90-day neurological recovery, whereas hypoxemia was associated with pulmonary infection.
- 23 February 2026
- Published by Wolters Kluwer Health in Journal of Neurosurgical Anesthesiology
- Vol. 38 (4) , 358-364
Early Oxygenation Levels and Clinical Outcomes in Postendovascular Therapy Ischemic Stroke: An Exploratory Analysis of the RESCUE-RE Registry
Background: Studies on oxygenation in acute ischemic stroke (AIS) mainly focus on the prehospital care and during endovascular therapy (EVT). This study aimed to explore the association between arterial oxygenation levels within the first 24 hours of intensive care unit (ICU) admission and neurological recovery, as well as pulmonary complications in AIS patients after EVT. Methods: We conducted an exploratory analysis of the multicenter RESCUE-RE registry, including 532 AIS patients who underwent EVT at 18 comprehensive stroke centers in China from January 2019 to June 2024. Patients were categorized by arterial blood gas measurements within 24 hours post-ICU admission into hypoxemia (PaO 2 120 mm Hg) groups. The primary outcome was functional independence (modified Rankin Scale [mRS] score 0 to 2) at 90 days. Secondary outcomes included other mRS thresholds, 90-day all-cause mortality, neurological improvement/deterioration, and pulmonary infection incidence. Multivariable regression adjusted for confounders assessed associations between PaO 2 levels and outcomes. Results: Functional independence rates at 90 days did not differ significantly among hypoxemia (26.8%), normoxemia (27.2%), and hyperoxemia (24.5%) groups ( P =0.788). Adjusted analyses showed no significant association between PaO 2 levels and neurological outcomes or mortality. Secondary outcomes, including neurological changes, were also comparable across groups. Notably, normoxemia and hyperoxemia were associated with significantly lower pulmonary infection risk compared with hypoxemia (adjusted ORs: 0.48 to 0.63). Conclusions: In AIS patients undergoing EVT, early postoperative arterial oxygenation was not associated with 90-day neurological recovery, whereas hypoxemia was associated with pulmonary infection.